Nir Nimrodi - 04 Sep 2026 Form 4 Insider Report for Evogene Ltd. (EVGN)

Reporting relationship: Director
Issuer ticker: EVGN
Reported as of: 04 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Sep 2026, 08:09:19 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Nitsan Deutsch, attorney-in-fact

Key filing fact

Nir Nimrodi filed Form 4 for Evogene Ltd. (EVGN) on 30 Sep 2026.

Key facts

This page summarizes Nir Nimrodi's Form 4 filing for Evogene Ltd. (EVGN).
1 reported transaction and 4 derivative rows are listed below.
Accepted by SEC: 30 Sep 2026, 08:09.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001602806 Primary reporting owner

Nimrodi Nir

Relationship: Director
Address: 291 CHINQUAPIN AVE, CARLSBAD
Signature: /s/ Nitsan Deutsch, attorney-in-fact
Signature date: 29 Sep 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EVGN transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +10,000
Change %
Price: $0.000000^*
Shares after: 10,000
Date: 04 Sep 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 10,000
Exercise price: $0.5800
Footnotes: F1, F2, F3

EVGN holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,625
Date: 04 Sep 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 5,625
Exercise price: $11.00
Footnotes: F4

EVGN holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,800
Date: 04 Sep 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,800
Exercise price: $10.20
Footnotes: F4

EVGN holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,000
Date: 04 Sep 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 10,000
Exercise price: $1.29
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The exercise price of the stock options to purchase Ordinary Shares of the Issuer (the "Options") is New Israeli Shekels ("NIS") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date.

Footnote F2

The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 10,000 Options. The Options were granted pursuant to, and are subject to the terms of, the Issuer's 2021 Share Incentive Plan.

Footnote F3

The Options vest and become exercisable on a quarterly basis (25% per quarter) commencing on the grant date of September 4, 2026, such that they will be fully vested by September 4, 2027, the one-year anniversary of the grant date.

Footnote F4

There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

SEC remarks

Exhibit 24.1 - Power of Attorney.